Page 80 - FINAL PROGRAMME 2017
P. 80
MONDAY, 3 JULY 2017
SELECTED ORAL COMMUNICATIONS
15:15 - 16:30 Room W+X
Session 20: Different types of pluripotent stem cells
Chairman: B. Heindryckx (Belgium) Chairman: C. Eguizabal (Spain)
15:15
15:30
O-076 Comprehensive cell-surface protein pro ling identi es novel markers of human naïve and primed pluripotent states
S. Panula1, A. Collier2, P. Rugg-Gunn2, F. Lanner1
1Karolinska Institutet, CLINTEC, Stockholm, Sweden
2The Babraham Institute, Epigenetics Programme, Cambridge, United Kingdom
O-077 Wnt inhibition during hESC culture provides an improved pluripotent state starting point for directed differentiation
J. Taelman1, L. Tilleman2, F. Van Nieuwerburgh2, S. Warrier1, M. Popovic1, M. Van Der Jeught1, D. Deforce2, P. De Sutter1, B. Heindryckx1, S.M. Chuva De Sousa Lopes3
1Ghent-Fertility and Stem Cell Team G-FAST, Department for Reproductive Medicine- Ghent University Hospital, Ghent, Belgium
2Laboratory of Pharmaceutical Biotechnology, Faculty of Pharmaceutical Sciences- Ghent University, Ghent, Belgium
3Leiden University Medical Centre, Department of Anatomy and Embryology, Leiden, The Netherlands
O-078 Origins of human embryonic stem cell fate: role of the post inner cell mass intermediate
S. Warrier1, M. Popovic1, J. Taelman1, L. Tilleman2, S. Lierman1, M. Ferrer-Buitrago1,
S. Chuva De Sousa Lopes3, A. Van Soom4, L. Peelman5, F. Van Nieuwerburgh2, D. Deforce2, P. De Sutter1, B. Heindryckx1
1Ghent University Hospital, Ghent-Fertility and Stem cell Team- G-FaST- Department for Reproductive Medicine, Ghent, Belgium
2Ghent University, Laboratory for Pharmaceutical Biotechnology- Faculty of Pharmaceutical Sciences, Ghent, Belgium
3Leiden University Medical Center-, Department of Anatomy and Embryology, Leiden, The Netherlands
4Ghent University, Department of Reproduction- Obstetrics and Herd Health- Faculty of Veterinary Medicine, Merelbeke, Belgium
5Ghent University, Department of Nutrition- Genetics and Ethology- Faculty of Veterinary Medicine, Merelbeke, Belgium
15:45
80